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Abstract: The bioorganometallic III containing trimethylene chain between ferrocene and resveratrol (3,5,4'-trihydroxystilbene, RSV) moieties 
connected via ester bond has been synthesized. The novel bioconjugate was characterized using IR and NMR (1H, 13C, COSY, NOESY, HMBC) 
spectroscopy, ESI-MS and HRMS. The RSV and ferrocene-RSV conjugate III were screened in vitro for their inhibitory effects against proliferation 
of hepatoblastoma (Hep G2) cells by MTT assay. Also, possible cytotoxicity towards normal ovary cells (CHO-K1) was evaluated. The obtained 
data revealed profound effects in biological/cytotoxic activity of III vs. RSV in Hep G2 cell line. Lower cytotoxicity of III was observed in normal 
ovary cells as compared to hepatoblastoma cells. 
 





WING to its therapeutic and protective role, resve-
ratrol [3,5,4'-trihydroxystilbene (RSV) (Figure 1a)] 
came into focus of research in recent years. Among 
numerous health benefits, RSV improves cardioprotection, 
cancer prevention and therapy, immune regulation and  
metabolic and neuroprotective functions.[1−3] In order to 
enhance its activity, RSV was derivatized by: (i) 
modification of the number and position of the phenolic 
groups, (ii) insertion of a long alkyl chains or functio-
nalized chains[4] and (iii) the addition of acyl chains to free 
hydroxyl groups.[5] The improved biological activity of the 
so-obtained RSV derivatives in comparison to those of the 
parent molecule is likely to be due to their lipophilicity 
and facilitated transport through cell membrane. 
Recently, RSV-derivatives I and II containing lipophilic 
ferrocene moiety instead of one benzene ring were 
synthesized (Figure 1b).[4] The heteroannularly disubsti-
tuted derivative IIb, containing additional aromatic unit 
linked by an ester bond, was found to exhibit more than 
10-fold higher inhibitory activity in SW480 and HepG2 cell 
lines compared to those of RSV. Prompted by these 
results, we have prepared and tested conjugate III 
containing trimethylene alkyl chain between ferrocene 
and RSV connected via ester linkage (Figure 1c). 
 
EXPERIMENTAL 
The material and methods data are provided in Supplemen-
tary Materials. 
O 
Figure 1. The chemical structures of (a) resveratrol (RSV), (b) 
ferrocene-RSV analogs I and II and (c) ferrocene-RSV
conjugate III. The numbering of the carbon atoms is 
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The trans-resveratrol (RSV) (95 mg, 0.42 mmol) was 
dissolved in dry THF (7 ml) and added to a solution of 
ferrocene butyric acid 1[6] (374 mg, 1.37 mmol) in the same 
solvent (10 ml), followed with addition of DMAP (7.6 mg, 
0.06 mmol) and NEt3 (0.35 ml, 2.49 mmol)[7] (Scheme 1). 
The reaction mixture was cooled to −15 °C and soluƟon of 
Boc2O (354 mg, 1.62 mmol) in dry THF (8 ml) was added. 
After 5 minutes, the reaction mixture was allowed to warm 
to room temperature and then stirred at ambient 
temperature during 5 days. After the total consumption of 
the starting material, as monitored by TLC, the mixture was 
diluted with EtOAc (10 ml) and washed with 2M HCl (30 ml), 
5 % NaHCO3 (50 ml) and saturated NaCl. The organic layer 
was dried over Na2SO4 and evaporated in vacuo to leave the 
crude product. Since the numerous yellow and UV visible 
spots were seen on TLC plate, the TLC purification of the 
crude material was repeated for several times using 
different solvent systems (petroleum ether/ diethyl ether = 
2/1; petroleum ether/ diethyl ether = 5/1; CH2Cl2 /hexane 
= 3/1) until satisfactory purity of the compound III was 
obtained and confirmed by ESI-LC method. Yellow-orange 
oil; 43 mg (21 %); Rf = 0.68 in petroleum ether/ diethyl ether 
= 2/1; IR (CH2Cl2) ṽmax/cm−1: 3676 w (OH), 1759 s (C=O), 
1137 s (CO); 1H NMR (CDCl3) /ppm: 1.54 (brs, 2H, OH), 1.96 
(m, 2H, CH2γ), 2.48 (t, J = 2.5 Hz, 2H, CH2δ), 2.58 (t, J = 2.6 
Hz, 2H, CH2β), 4.08 (s, 2H, HFn), 4.11 (s, 2H, HFn), 4.12 (s, 5H, 
HFn), 6.90 (pt, 1H, H4), 6.97 (d, J = 16.3 Hz, 1H, Hα), 7.06 (d, 
J = 16.3 Hz, 1H, Hα'), 7.11 (brs, 1H, H2), 7.17 (d, J = 8.5 Hz, 
2H, H3’, H5’), 7.19 (brs, 1H, H2), 7.47 (d, J = 8.5 Hz, 2H, H2’, 
H6’); 13C NMR APT (CDCl3) /ppm: 171.70 (C=O), 151.89 
(C3), 151.88 (C5), 151.47 (C4'), 139.63 (C1), 134.53 (C1'), 
129.78 (Cα'), 172.75 (C2', C6'), 129.38 (Cα), 121.74 (C3', 
C5'), 116.90 (C6), 116.68 (C2), 116.59 (C4), 84.03 (CqFn), 
68.70, 68.32, 67.48 (CFn), 34.05 (CH2β), 29.11 (CH2δ), 26.28 
(CH2γ); ESI-MS m/z = 583.2 [(M+2MeOH+2H2O+H)+]; 
MALDI-HRMS m/z = 482.118 (calculated for C28H26O4Fe = 
482.118). 
Cytotoxic Activity 
Treatment: Stock solutions of RSV and ferrocene-RSV 
conjugate III were prepared as 20 mM solutions in ethanol 
(EtOH) and stored at 4° C. Prior to use in cytotoxicity assay, 
the stock solutions were further diluted with culture 
medium to obtain final concentrations (10–100 μM). 
Cytotoxic effects in Hep G2 and CHO-K1 cells were 
evaluated after 48 h of exposition. Samples with ethanol 
without test compounds were used as controls. 
 MTT Cytotoxicity Assay: For experimental purposes 
cells were seeded in multiwell plates (5  104 cells/mL), then 
treated with RSV and III at a range of concentrations 
(10−100 μM) and after 48 h cell viability was determined 
by MTT assay.[8] The experiments were performed two 
times with at least three parallels for each concentration 
and data were expressed as the means ± SEM. Cell viability 
was expressed as percentage of treated cells vs. control 
cells. The IC50 values, defined as the concentrations of the 
tested compound that result in 50 % cell growth inhibition, 
were derived from the equations of related trend lines. 
 Statistical Analysis: A two-tailed Student's t-test was 
applied to evaluate the significant differences between 
control and treated cells. The results are reported as means 
± SEM, p < 0.05 was considered significant. 
 
RESULTS AND DISCUSSION 
The conjugate III was prepared by esterification[7] of 
ferrocene butyric acid (1)[6] with C3-OH group of trans-RSV 
in the presence of DMAP, NEt3 and Boc2O (Scheme 1). 
Although the reaction conditions were adjusted to provide 
the simultaneous formation of mono- (III), di- and three 
esterified conjugates, we were able to isolate and confirm 
the presence of only one pure compound, i.e. monoester III 
in yield of 21 %. However, TLC-plate indicated the presence 
of a several yellow-coloured ferrocene-containing com-
pounds that had proved to be difficult to purify to the 
required level. 
 The NMR assignments in the present study are in a 
good agreement with previously published data for RSV[9,10] 
and its 3-substituted RSV-glycoside[11] (Table 1). 
 The 1J(H,H) coupling between two alkene hydrogens 
α and α' of 16.5 Hz is consistent with the trans orientation 
of the phenolic rings. MS and NMR data unambiguously 
confirmed the presence of one single ferrocene moiety, 
introduced by esterification of C3-OH group of RSV. As it 
was shown for 3-substituted RSV-glycoside[11], the clearly 
separated NMR signals of C2 and C6, C3 and C5 and H2 and 
H6 in comparison to magnetically equivalent assignments 
for H2'/6', H3'/5', C2'/6' and C3'/5' indicate the alteration 
of their chemical environment due to the esterification of 
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C3-OH group. Furthermore, the NOE contacts between free 
hydroxyl protons on C4' and C5 with H3'/5' and H4, respec-
tively, and CH2β and CH2γ with H2 and H4 support the 
proposed structure (Figure 2). 
 The six protons from alkyl chain were observed as 
two triplets at δ 2.85 and 2.48 ppm and one multiplet at 
1.96 ppm. Multiple resonances detected for the same 
proton during the course of NMR analysis are attributed to 
the presence of 5:95 cis-trans mixture of RSV. 
 The RSV and ferrocene-RSV conjugate III were 
evaluated in vitro as inhibitors of hepatoblastoma (Hep G2) 
cell proliferation. Also, possible cytotoxicity towards 
normal ovary cells (CHO-K1) was evaluated. The concen-
tration-dependent analysis of the cytotoxicity was evalu-
ated by the widely used MTT method. The summarized 
results of cytotoxicity evaluation in Hep G2 and CHO-K1 cell 
lines with MTT bioassay are presented in Figure 3. IC50 
values shown in Table 2 were derived from the equations 
of related polynomial trend lines for RSV and III, in both 
cell lines. 
 Presented data reveal profound effects in biological 
activity of ferrocene-RSV conjugate III vs. RSV in 
hepatoblastoma cell line. III in concentrations of 35, 75 and 
100 μM significantly (p<0.001 – p<0.5) decreased Hep G2 
cell proliferation (Figure 3a) and in all tested concentrations 
inhibitory effect is more pronounced for III compared to the 
same doses of RSV. This finding is also supported by 
comparison of IC50 values in Hep G2 cells: IC50 value for III is 
20 % lower than IC50 value for RSV[4] (Table 2). The results 
in normal CHO-K1 cells (Figure 3b), as opposite to those 
obtained in Hep G2 carcinoma cells, indicate much lower 
cytotoxicity of III to normal cells – in fact, there was no 
statistically significant cytotoxicity observed in normal cells, 
except for the highest tested concentration (100 µM) and 
IC50 value was out of the applied concentration range. 
 
CONCLUSION 
The previously described ferrocene-RSV derivative IIb, 
containing two benzene, one ferrocene and one ester group, 
displayed higher inhibitory activity in SW480 and HepG2 cell 
lines as compared to RSV, owing to its enhanced lipophilicity. 
With that in mind, we have synthesized conjugate III com-
prised of the same elements but with different structural and 
spatial patterns and equipped with additional trimethylene 
alkyl chain in order to improve its lipophilicity as a crucial 
requirement for biological activity. Although the novel 
conjugate III is found to be less active than IIb, it is more 
potent in comparison to RSV. Therefore, the herein presen-
ted preliminary results hold potential for further studies of 
ferrocene-RSV conjugates based on multi-method approach 
in order to obtain more detailed information. 
Table 1. NMR (δ in ppm) spectroscopic data of RSV,[9,10] RSV-glycoside[11] and ferrocene-RSV conjugate III (c = 110−3 mol dm−3)
C and 
attached 1H 
Carbon, δ / ppm Proton, δ / ppm 
RSV* RSV-glycoside* III** RSV* RSV** RSV-glycoside* III** 











4 101.67 104.7 114.20 6.07 6.21 6.33 6.90 
 125.60 125.1 127.35 6.76 6.80 6.86 6.97 
' 128.02 128.5 129.75 6.87 6.97 7.01 7.06 
1' 128.07 129.9 134.49 - - - - 
2',6' 127.75 127.9 127.73 7.35 7.35 7.39 7.47 
3',5' 115.43 115.5 121.68 6.71 6.81 6.76 7.17 






- - - - 
*NMR spectra were recorded in DMSO-d6. 
**NMR spectra were recorded in CDCl3. 
 
 
Table 2. IC50 values (μM) for RSV and ferrocene-RSV
conjugate III vs. hepatoblastoma (Hep G2) cells and normal 
ovary cells (CHO-K1) revealed by MTT cytotoxicity assay 
Compound 
IC50 (M) 
Hep G2 CHO-K1 
RSV 121.5 99.0 
III 98.3 n.d. 
n.d. – non determinated IC value for the corresponding incubation period, 
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Figure 3. In vitro anti-proliferative effect of RSV and ferrocene-RSV conjugate III against (a) hepatoblastoma (Hep G2) cells and 
(b) normal ovary cells (CHO-K1), obtained with MTT assay after 48 h exposure. Data are presented as percentage of control: 
mean  SEM of 2 experiments with at least three measurements within each experiment for each concentration. Statistical 






















































Materials and methods 
Chemistry: Reaction was carried out under argon atmosphere. The THF used for synthesis was dried 
and distilled over CaH2 and stored over molecular sieves (4Å). The synthesis of ferrocene butyric 
acid was performed according to literature data[6]. Trans-resveratrol (RSV) (Sigma-Aldrich), di-tert-
butyldicarbonate (Acros Organics), NEt3 (Fischer Chemical) and DMAP (Sigma-Aldrich) were used 
as received. Product was purified by preparative thin layer chromatography on silica gel (Merck, 
Kieselgel 60 HF254). Infrared spectrum was recorded as CH2Cl2 solution between NaCl windows by 
using a Bomem MB 100 mid FTIR spectrometer. (s) = strong, (w) = weak. The 1H NMR spectra 
measured at 600.133 MHz and 13C NMR spectra measured at 150.917 MHz using Bruker Avance 
spectrometer, were referenced to the residual solvent peak (CDCl3, 1H: 7.26 ppm, 13C: 77.16 ppm). 
Double resonance experiments (COSY, NOESY, HMBC) were performed in order to assist in signal 
assignment. (s) = singlet, (brs) = broad singlet, (d) = doublet, (t) = triplet, (m) = muliplet, (pt) = 
pseudotriplet (unresolved doublet of doublets). Mass spectra were measured on a LC-MS system 
coupled with triple-quadrupole mass spectrometer, operating in a positive ESI mode (H2O/MeOH = 
80/20). High-resolution mass spectrum was acquired using 4800 MALDI TOF/TOF-MS Analyzer. 
Cell culture: Hep G2 (human hepatoblastoma cell line; ATCC® HB-8065™) and CHO-K1 (chinese 
hamster ovary; ATCC® CCL61™) cell lines were purchased from American Type Culture Collection 
(ATCC, USA). Hep G2 and CHO-K1 cells were maintained in Dulbecco's Modified Eagle Medium 
Nutrient Mixture F-12 with 15 mM HEPES buffer and L-glutamine (DMEM/F-12 (1:1); Gibco, 
Paisley, UK). Heat inactivated Fetal Bovine Serum (Gibco, Paisley, UK) was added to make the 
complete growth medium for both cell cultures in final concentration of 10 %. Cells were routinely 
cultured in 80-cm2 cell flasks (Nunc, Roskilde, Denmark) at 37° C and humidified in atmosphere of 
5 % CO2 in air. After reaching 70-90 % confluence cells were disaggregated using a trypsin/EDTA 
(0.25 % trypsin, 1mM EDTA4Na), counted and placed at the necessary density prior to sub-culture 
or seeding in wells for experimental needs.  
Treatment: Hep G2 and CHO-K1 cells in log phase of growth were seeded in 96-well plates (100 µL 
of cell solution per well) at the initial concentration of 5  104 cells/mL and allowed 24 h to attach 
before treatment with RSV and ferrocene-RSV conjugate. Stock solutions of RSV and ferrocene-
RSV conjugate III were prepared as 20 mM solutions in ethanol (EtOH) and stored at 4° C. Prior to 
use in cytotoxicity assay, the stock solutions were further diluted with culture medium to obtain final 
concentrations (10-100 μM). After 24 h, the media was replaced with fresh one containing different 
concentrations of RSV or ferrocene-RSV conjugate III. Cytotoxic effects were evaluated after 48h 
of exposition. Samples with ethanol without test compounds were used as controls. Final 
 
 
concentration of ethanol did not exceed 0.5 % and had no interference with the biological activities 
tested. Cytotoxic effects were evaluated after 48h of exposition.  
MTT Cytotoxicity Assay: The cytotoxicity of RSV and ferrocene-RSV conjugate III was determined 
by MTT assay. Cells were incubated with tetrazolium salt MTT {3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide} for 4h. The absorbance was measured at 570 nm on the microplate 
reader (microplate reader, model LKB 5060-006, LKB Vertriebs GmbH, Vienna, Austria). 
 
